Trial of Hypofractionated Post-Prostatectomy Radiation Therapy vs Conventional Post-Prostatectomy Radiation TherapyStatus: open
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
Treatment for Prostate Cancer
This randomized phase III trial studies how well hypofractionated radiation therapy works compared to conventional radiation therapy after surgery in treating patients with prostate cancer.
SponsorsThis trial is sponsored by NRG Oncology.
Interested in Clinical Trial?
Providers Associated With This Trial
- Elesyia D. Outlaw, M.D.Radiation OncologistDirector of Women's Radiotherapy Program; Program Director of Brachytherapy Program; Associate Professor of Interdisciplinary Clinical Oncology